Low frequency of p53 mutations in cervical carcinomas among Brazilian women

Brazilian Journal of Medical and Biological Research

Volumn 34, Issue 6, 2001, Pages 727-733

  Pinheiro, N A ^a,b   Villa, L L ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

DNA sequencing; HPV; PCR; Single stranded conformation polymorphism; SSCP; Suppressor gene

Indexed keywords

HUMAN PAPILLOMAVIRUS;

PRIMER DNA;

ARTICLE; BRAZIL; EXON; FEMALE; GENE FREQUENCY; GENETICS; HUMAN; MUTATION; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UTERINE CERVIX TUMOR; VIROLOGY;

BASE SEQUENCE; BRAZIL; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; EXONS; FEMALE; GENE FREQUENCY; GENES, P53; HUMANS; MUTATION; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; UTERINE CERVICAL NEOPLASMS;

EID: 0035377384     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2001000600005     Document Type: Article

References (41)

1. Villa LL (1997). Papillomaviruses and cervical cancer. Advances in Cancer Research, 71: 321-341.
2. Zur Hausen H (1996). Papillomavirus infections - a major cause of human cancers. Biochimica et Biophysica Acta, 1288: F55-F78.
3. Bosch FX, Manos VIM, Mun̄oz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV & Internatonal Biological Study on Cervica Cancer (IBSCC) Study Group (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. Journal of the National Cancer Institute, 87: 796-802.
4. Borresen AL, Helland A, Nesland J, Holm R, Trope C & Kaern J (1992). Papillomaviruses, p53, and cervical cancer. Lancet, 339: 1350-1351
5. Dyson N, Howley PM, Münger K & Harlow E (1989). The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 243: 934-937.
6. Scheffner M, Munger K, Byrne JC & Howley PM (1991). The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proceedings of the National Academy of Sciences, USA, 88: 5523-5527.
7. Wrede D, Tidy JA, Crook T, Lane D & Vousden KH (1994). Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines. Molecular Carcinogenesis, 4: 171-175.
8. Huibregtse JM, Scheffner M & Howley PM (1994). E6-AP directs the HPV E6-dependent inactivation of p53 and is representative of 3 family of structurally and functionally related proteins. Cold Spring Harbor Symposia on Quantitative Biology, LIX: 237-245.
9. Lane DP & Crawford LV (1979). T antigen is bound to a host protein in SV40-transformed cells. Nature, 278: 261-263.
10. Reich NC, Oren M & Levine AJ (1983). Two mechanisms regulate the levels of a cellular tumor antigen, p53. Molecular and Cellular Biology, 3: 2143-2150.
11. Levine AJ, Momand J & Finlay CA (1991). The p53 tumour suppressor gene. Nature, 351: 453-456.
12. Funk WD, Pak DT, Karas RH, Wright WE & Shay JW (1992). Transcriptionally active DNA-binding site for human p53 protein complexes. Molecular and Cellular Biology, 12: 2866-2871.
13. Hollstein M, Sidransky D, Vogelstein B & Harris CC (1991). p53 mutations in human cancers. Science. 253: 49-53.
14. Busby-Earle RMC, Steel CM, Williams ARW, Cohen B & Bird CC (1992). Papillomaviruses, p53 and cervical carcinoma. Lancet, 339: 1350.
15. Crook T, Wrede D & Vousden KH (1991). p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene, 6: 873-875.
16. Srivastava S, Tong YA, Devadas K, Zou ZQ, Chen Y, Pirollo KF & Chang EH (1992). The status of the p53 gene in human papilloma virus positive or negative cervical carcinoma cell lines. Carcinogenesis, 13: 1273-1275.
17. Park DJ, Wilczynski SP, Paquette RL, Miller CW & Koeffler HP (1994). p53 mutat ons in HPV-negative cervical carcinoma. Oncogens, 9: 205-210.
18. Crock T & Vousden KH (1992). Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO Journal, 11: 3935-3940.
19. Krieg P, Antmann E & Sauer G (1983). The simultaneous extraction of high molecular weight DNA and of RNA from solid tumours. Analytical Biochemistry, 134: 288-294.
20. Bauer HM, Yi Ting MS, Chambers JC, Tashiro CJ, Chimera J, Reingold A & Manos MM (1991). Genital human papillomavirus infection in female university students as determined by PCR-based methods. Journal of the American Medical Association, 265: 23-30.
21. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ & Munoz N (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189: 12-19.
22. Hayashi K, Orita M, Suzuki Y & Sekiya T (1989). Use of labeled primers in polymerase chain reaction (LP-PCR) for a rapid detectior of the product. Nucleic Acids Research, 17: 3605.
23. Kishimoto Y, Murakami Y, Shiraishi M, Hayashi K & Sekiya T (1992). Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Research, 52: 4799-4804.
24. Murakami Y, Hayashi K & Sekiya T (1991). Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis. Cancer Research, 51: 3356-3361.
25. Orita M, Iwahana H, Kanazawa H, Hayash K & Sekiya T (1989). Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proceedings of the National Academy of Sciences, USA, 86: 2766-2770.
26. Scheffner M, Werness BA, Huibregtse JM, Levine AJ & Howley PM (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136.
27. Werness BA, Levine AJ & Howley PM (1990). Association of human papillomavirus types 16 and 18. Science, 248: 76-79.
28. Liang XH, Volkman M, Klein R, Herman B & Lockett SJ (1993). Co-localization of the tumor-suppressor protein o53 and human papillcmavirus E6 protein in human cervical carcinoma cell lines. Oncogens, 8: 2645-2652
29. Busby-Earle RM, Steel CM, Williams AR, Cohen B & Bird CC (1994). p53 mutations in cervical carcinogenesis - low frequency and lack of correlation with human papillomavirus status. British Journal of Cancer, 69: 732-737.
30. Kong G, Choo B & Chong KY (1993). Absence of mutation in the p53 and the retinoblastoma susceptibility genes in primary cervical carcinomas. Virology, 193: 1042-1046.
31. Helland A, Holm R, Kristensen G, Kaern J, Karesen F, Trope C, Nesland JM & Børresen A-L (1993). Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. Journal of Pathology, 171: 105-114.
32. Choo KB, Chong KY, Liew L-N & Hsu Cheng W (1993). Unregulated and basal transcriptional activities of the regulatory sequence of the type 18 human papillomavirus genome n transgenic mice. Journal of Virology, 188: 378-383.
33. Kim JW, Cho YH, Lee CG, Kim JH, Kim HK, Kin EJ, Ham KT & Namkoong SE (1997). Human papillomavirus infection and TP53 gene mutation n primary cervical carcinoma. Acta Oncologica, 36: 295-300.
34. Kim KH & Kim YS (1995). Role of human papillomavirus and p53 tumor suppressor gene in cervical carcinogenesis. Yonsei MedicalJ ournal, 36: 412-425.
35. Nakagawa S, Yoshikawa H, Jimbo H, Onda T, Yasugi T, Matsumoto K, Kino N, Kawana K, Kozuka T, Nakagawa K, Aoki M & Taketani Y (1999). Elderly Japanese women with cervical carcinoma show higher proportions of both intermediaterisk human papillomavirus types and p53 mutations. British Journal of Cancer, 79: 1139-1144.
36. Levi JE, Rahal P, Sarkis AS & Villa LL (1998). Human papillomavirus DNA and p53 status in penile carcinomas. International Journal of Cancer, 76: 779-783.
37. Soussi T, Caron de Fromentel C & May P (1990). Structural aspects of the p53 protein in relation to gene evolution. Oncogens, 5: 945-952.
38. Pao CC, Kao SM, Tang GC, Lee KSIJ & Ruan S (1993). Human papillomavirus and cervical carcinoma in China and Taiwan. Lancet, 342: 937.
39. Chen TM, Chen CA, Hsieh Cy, Chang DY, Chen Yh & Defendi V (1992). The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells. Oncogene, 8: 1511-1518.
40. Kurvinen K, Tervahauta A, Syrjanen S, Chang F & Syrjanen K (1994). The state of the p53 gene in human papillomavirus (HPV)-positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analyse and sequencing. Anticancer Research, 14: 177-181.
41. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ & Vousden KH (1992). Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumors. Lancet, 339: 1070-1073.